Valeant Pharmaceuticals reported $442M in Trade Creditors for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Creditors Change
Amgen AMGN:US $ 1277M 119M
Ani Pharmaceuticals ANIP:US $ 12.98M 792K
Aurora Cannabis Inc ACB:CN C$ 13.28M 142K
Biogen BIIB:US $ 427.9M 52.6M
Bristol Myers Squibb BMY:US $ 3609M 637M
Canopy Growth Corp WEED:CN C$ 91.34M 24.08M
Catalent CTLT:US $ 385M 19.3M
Corcept Therapeutics CORT:US $ 9.22M 2.25M
Danaher DHR:US $ 2133M 166M
Drreddys Laboratories RDY:US $ 28607M 4863M
Endo International Ordinary Shares ENDP:US $ 103.84M 0.68M
Gw Pharmaceuticals GWPH:US $ 16.67M 5.2M
Horizon Pharma HZNP:US $ 51.95M 8.96M
JAZZ PHA JAZZ:US $ 64.83M 12.91M
Lannett LCI:US $ 29.58M 3.02M
Nektar Therapeutics NKTR:US $ 19.7M 2.73M
Pacira Pharmaceuticals PCRX:US $ 12.18M 3.07M
Perrigo Ordinary Shares PRGO:US $ 402.4M 27.9M
Phibro Animal Health PAHC:US $ 68.36M 5.56M
Prestige Brands PBH:US $ 30.96M 15.02M
Revance Therapeutics RVNC:US $ 8.18M 1.1M
Valeant Pharmaceuticals VRX:CN $ 442M 100M
Vertex Pharmaceuticals VRTX:US $ 127.53M 0.3M
Zoetis ZTS:US $ 369M 23M